ImmuCell Corporation
ICCC US4525253062
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Gathagan Bryan K. O |
6.32 USD |
1,000 Bought |
6,320 USD |
12/06/2025 | 12/06/2025 |
| Gathagan Bryan K. O |
6.32 USD |
1,000 Bought |
6,320 USD |
12/06/2025 | 12/06/2025 |
| Tomsche David Scott O |
3.55 USD |
2,186 Bought |
7,760 USD |
28/08/2024 | 28/08/2024 |
| Tomsche David Scott O |
3.55 USD |
6,005 Bought |
21,318 USD |
23/08/2024 | 23/08/2024 |
| Tomsche David Scott O |
3.55 USD |
10,000 Bought |
35,500 USD |
22/08/2024 | 22/08/2024 |
| Tomsche David Scott O |
3.67 USD |
3,172 Bought |
11,641 USD |
15/08/2024 | 19/08/2024 |
| Tomsche David Scott O |
3.72 USD |
4,811 Bought |
17,883 USD |
15/08/2024 | 16/08/2024 |
| Tomsche David Scott O |
3.57 USD |
2,017 Bought |
7,195 USD |
15/08/2024 | 15/08/2024 |